CCS
OPK icon

Crosspoint Capital Strategies’s Opko Health OPK Stock Holding History

Crosspoint Capital Strategies’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-750
Closed -$7K – 606
2014
Q1 		$7K Hold
750
– – ﹤0.01% 521
2013
Q4 		$7K Buy
+750
New +$7.58K ﹤0.01% 460

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OHCM
Orchard Hill Capital Management New York $22.6M AUM 3.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Crosspoint Capital Strategies's OPK Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Opko Health (OPK) in Q2 2014, closing a stake of 750 shares — an estimated $7K sold.

Crosspoint Capital Strategies first reported a position in OPK in Q4 2013 and held it in 2 quarters. The position peaked at $7K in Q1 2014. 175 funds tracked by Wall St. Rank hold OPK as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Opko Health position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 750 Opko Health shares in Q2 2014, an estimated $7K.
  • Crosspoint Capital Strategies first reported a position in Opko Health in Q4 2013 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Opko Health position peaked at $7K in Q1 2014.
  • 175 funds tracked by Wall St. Rank held Opko Health as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.